CEO
PI
PEPGENE Inc.
The startup develops biosimilar production technology specifically for peptide and protein drugs, focusing on methods that enhance the efficiency of biosimilar manufacturing. This technology addresses the need for effective treatments for diseases such as obesity, diabetes, and rare conditions while minimizing side effects.
- Biotechnology
Updated 6 months ago
Funding
Raised to date
$590KRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops biosimilar production technology specifically for peptide and protein drugs, focusing on methods that enhance the efficiency of biosimilar manufacturing. This technology addresses the need for effective treatments for diseases such as obesity, diabetes, and rare conditions while minimizing side effects.